Stockscreener 앱 받기
14.29
2.86%
-0.42
시간 외 거래:
14.29
전일 마감가:
$14.71
열려 있는:
$14.7
하루 거래량:
85,477
Relative Volume:
0.97
시가총액:
$183.66M
수익:
$16.96M
순이익/손실:
$-23.88M
주가수익비율:
-6.8145
EPS:
-2.097
순현금흐름:
$-20.66M
1주 성능:
-5.74%
1개월 성능:
+3.10%
6개월 성능:
-23.58%
1년 성능:
-32.24%
1일 변동 폭
$14.16
$14.77
1주일 범위
$14.16
$15.19
52주 변동 폭
$13.54
$21.23
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
14.29 | 189.06M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 126.01B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 70.03B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 56.56B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 40.63B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-02 | 개시 | Alliance Global Partners | Buy |
| 2025-02-28 | 개시 | Craig Hallum | Buy |
| 2024-07-16 | 재확인 | Maxim Group | Buy |
| 2022-12-22 | 개시 | Maxim Group | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-09-23 | 개시 | BTIG Research | Buy |
| 2016-11-28 | 개시 | Aegis Capital | Buy |
| 2016-08-17 | 개시 | Wells Fargo | Outperform |
| 2014-04-16 | 개시 | Oppenheimer | Outperform |
모두보기
Mediwound Ltd 주식(MDWD)의 최신 뉴스
(MDWD) Volatility Zones as Tactical Triggers - Stock Traders Daily
Enterprise value to EBITDA forward of MediWound Ltd. – NASDAQ:MDWD - TradingView
MDWDMediWound Ltd Volatility & Greeks - Finviz
Enterprise value to revenue forward of MediWound Ltd. – FWB:M8W - TradingView
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Value-Defensive Index - marketscreener.com
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index - marketscreener.com
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Defensive Index - marketscreener.com
Price-Driven Insight from (MDWD) for Rule-Based Strategy - Stock Traders Daily
Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
M8W Forecast — Price Target — Prediction for 2027 - TradingView
MediWound Ltd. Actuals & Estimates (NASDAQ:MDWD) - TradingView
Enterprise value to EBITDA forward of MediWound Ltd. – SWB:M8W - TradingView
MDWD Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of MediWound Ltd. – NASDAQ:MDWD - TradingView
Price to earnings forward of MediWound Ltd. – SWB:M8W - TradingView
Price to book forward of MediWound Ltd. – SWB:M8W - TradingView
Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mediwound Ltd (MDWD) Institutional Confidence - TradingKey
MediWound (MDWD) Holds Near Support After Marginal Gain, Biotech Sector in FocusCall Resistance - dars.gov.et
Mediwound Ltd (MDWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDWD Q1 2026 Earnings: EPS Beat Driven by Operational ImprovementsNet Income Trends - dars.gov.et
MDWD Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts SentimentEarnings Growth Analysis - newsline.com
MDWD Q1 2026 Earnings: Strong Beat on EPS Despite Narrower LossEarnings Per Share - newsline.com
MDWD Q1 2026 Earnings: Significant EPS Beat Drives Positive Sentiment Despite Absent RevenueCost Structure Review - newsline.com
MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Surprises to the UpsideGeographic Revenue Trends - newsline.com
MediWound (MDWD) Sheds 1.87% as Stock Holds Above Key Support LevelAccumulation Line - newsline.com
MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47Wave Equality - newsline.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD) - MarketBeat
Maxim Group Issues Negative Estimate for MediWound Earnings - MarketBeat
Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD) - GuruFocus
Director at MediWound (MDWD) buys 6,000 ordinary shares in market - Stock Titan
MediWound Ltd. Stock Plummets to New 52-Week Low of $13.58 - Markets Mojo
Insider Buying: David Fox Acquires Shares of MediWound Ltd (MDWD) - GuruFocus
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) director buys 3,537 ordinary shares on open market - Stock Titan
MediWound Q1 earnings call highlights - MSN
Director Rubinstein buys MediWound (MDWD) shares and holds multiple options - Stock Titan
MediWound Shares Slide This Week; BARDA Moves in Focus - Bez Kabli
MediWound Ltd. Hits New 52-Week Low at USD 14.14 - MarketsMojo
MediWound Ltd. (MDWD) Q1 2026 Earnings: Significant EPS Beat Highlights Cost DisciplineGrowth Acceleration Report - dars.gov.et
MediWound (MDWD) Slips 1.58% as Stock Holds Near Critical Support at $13.61Price Momentum Stocks - The Legal Advocate
5 Stocks Better Than MediWound as Q1 Revenue Declines - HarianBasis.co
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
MDWD Maintains Outperform by Oppenheimer -- Price Target Lowered to $32 - GuruFocus
Mediwound Ltd (MDWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):